Results 71 to 80 of about 21,337,282 (283)

The biochemical and molecular characterisation of respiratory mucins in TB [PDF]

, 2006
Includes bibliographical references (leaves 96-112).The role of the dominant respiratory mucins (MUC5AC and MUC5B) and MUC2 has been investigated in chronic airway diseases as it is the mucin glycoprotein that confers upon mucus its biological ...
Govender, Ureshnie
core   +1 more source

National Center for Immunization and Respiratory Diseases [PDF]

The mission of the National Center for Immunization and Respiratory Diseases (NCIRD) is the prevention of disease, disability, and death through immunization and by control of respiratory and related diseases.

core  

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Analysis of spirometry results in hospitalized patients aged over 65 years

Clinical Interventions in Aging, 2015
Izabela Wróblewska,1 Piotr Oleśniewicz,2 Donata Kurpas,3 Mariusz Sołtysik,2 Jerzy Błaszczuk41Faculty of Health Science, Wroclaw Medical University, 2Institute of Tourism and Recreation, University School of Physical Education in Wroclaw ...
Wróblewska I, Oleśniewicz P, Kurpas D, Sołtysik M, Błaszczuk J   +4 more
doaj  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

New causative agents of respiratory tract diseases in immunocompromized patients (a review)

Наука и инновации в медицине, 2019
The diseases of the respiratory system occupy one of the leading positions in the range of morbidities among the Russian population, both in adults and children.
Danir D. Ismatullin, Maksim O. Zolotov, Artem V. Lyamin, Tatyana R. Nikitina, Elena A. Zheleznova, Aleksandr V. Zhestkov   +5 more
doaj   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

RECURRENT RESPIRATORY DISEASES IN CHILDREN AND THE STATE OF HUMORAL IMMUNITY

Медицинский вестник Юга России, 2015
Purpose: the aim of the study was to explore the features of humoral immunity in children 2-4 years with recurrent respiratory diseases attending organized children’s groups.Materials and Methods: 158 children aged 2 to 4 years were examined.
A. A. Lebedenko, A. M. Levchin, E. V. Nosova   +2 more
doaj   +1 more source

Middle East Respiratory Syndrome [PDF]

This podcast discusses Middle East Respiratory Syndrome, or MERS, a viral respiratory illness caused by Middle East Respiratory Syndrome Coronavirus\ue2\u20ac\u201dMERS-CoV.Podcast: 4.08Created: 7/7/2014 by National Center for Immunization and ...

core  

Prioritised research agenda for prevention and control of chronic respiratory diseases [PDF]

, 2010
The 2008–2013 World Health Organization (WHO) action plan on noncommunicable diseases (NCDs) includes chronic respiratory diseases as one of its four priorities.
Khaled, N.A., Khaltaev, N., Bousquet, J., Canonica, G. W., Cruz, A.A., Barreto, M. L., Bateman, ED, Gerbase, MW, Fabbri, L.M., Humbert, M., Canonica, GW, Khaled, NA, Rabe, K, Billo, N., Baena-Cagnani, C. E., Drazen, J, Baena-Cagnani, C.E., Rabe, K., Khaltaev, N, Masjedi, MR, Viegi, G, To, T, Joos, Guy, Gerbase, Margaret, Makino, S, Bousquet, J, Chuchalin, A, Viegi, G., Barreto, M.L., Carlsen, K-H, Kiley, J, Humbert, M, Canonica, G.W., Ait Khaled, N., Kiley, J., Chavannes, N, Billo, N, Masjedi, M. R., Zhi, L, Cruz, A. A., Drazen, J., Baena-Cagnani, CE, Fabbri, L. M., Carlsen, K.H., Masjedi, M.R., To, T., Cruz, AA, , T. to, Bateman, E. D., Makino, S., Barreto, ML, Zhi, L., Chuchalin, A., Gerbase, M.W., Joos, G., Carlsen, KH, Fabbri, LM, Bateman, E.D., Chavannes, N., Canonica GW, Rabe K, Baena Cagnani, Carlos E., ToT, Chavannes N, Bousquet, Jean, BaenaCagnani CE, Barreto ML, To T, Bousquet J, Masjedi MR, Drazen J, Zhi L., MakinoS, Aït Khaled N, Humbert M, Cruz AA, Viegi G, Khaltaev N, Kiley J, Makino S, Baena Cagnani CE, Fabbri LM, Carlsen KH, Canonica, Giorgio Walter, Zhi, Chuchalin A, Joos G, Gerbase MW, CANONICA, GIORGIO, Bateman ED, Billo N   +90 more
core   +1 more source